about
Spatially Discordant Alternans and Arrhythmias in Tachypacing-Induced Cardiac Myopathy in Transgenic LQT1 Rabbits: The Importance of IKs and Ca2+ CyclingIncreased afterload induces pathological cardiac hypertrophy: a new in vitro modelLoss of MD1 exacerbates pressure overload-induced left ventricular structural and electrical remodelling.Optical mapping of optogenetically shaped cardiac action potentialsAdverse remodeling of the electrophysiological response to ischemia-reperfusion in human heart failure is associated with remodeling of metabolic gene expression.CYP2J2 overexpression protects against arrhythmia susceptibility in cardiac hypertrophyInhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.Loss of ATP-Sensitive Potassium Channel Surface Expression in Heart Failure Underlies Dysregulation of Action Potential Duration and Myocardial Vulnerability to InjuryAldosterone down-regulates the slowly activated delayed rectifier potassium current in adult guinea pig cardiomyocytesCardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytesGender-based differences in cardiac diseasesChronic cyclic vagus nerve stimulation has beneficial electrophysiological effects on healthy hearts in the absence of autonomic imbalance.Pathological ventricular remodeling: mechanisms: part 1 of 2Calcineurin-dependent ion channel regulation in heart.KChIP2 is a core transcriptional regulator of cardiac excitability.Cardiac electrical remodeling in health and disease.Hypertrophic reprogramming of the left ventricle: translation to the ECGTransient outward potassium channel: a heart failure mediator.High resolution 3-Dimensional imaging of the human cardiac conduction system from microanatomy to mathematical modeling.Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment.Arrhythmogenic and metabolic remodelling of failing human heart.Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.Calcineurin signaling in the heart: The importance of time and place.Role of connexin-43 in protective PI3K-Akt-GSK-3β signaling in cardiomyocytes.Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanismsArrhythmogenic remodelling of activation and repolarization in the failing human heart.Astragalus Granule Prevents Ca2+ Current Remodeling in Heart Failure by the Downregulation of CaMKII.Familial long QT syndrome and late development of dilated cardiomyopathy in a child with a KCNQ1 mutation: A case report.Prolonged leptin treatment increases transient outward K⁺ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes.Kv4.3 expression reverses ICa remodeling in ventricular myocytes of heart failure.Left Ventricular Mechanical Reverse Remodelling Not Followed by Electrical Reverse Remodelling: A Case Report.Electrical field stimulation induces cardiac fibroblast proliferation through the calcineurin-NFAT pathway.TRPM4 non-selective cation channels influence action potentials in rabbit Purkinje fibres.Regulation of cardiac microRNAs induced by aerobic exercise training during heart failure.Aldosterone downregulates delayed rectifier potassium currents through an angiotensin type 1 receptor-dependent mechanism.Management of Arrhythmias in Heart Failure.Hypokalemia-Induced Arrhythmias and Heart Failure: New Insights and Implications for Therapy
P2860
Q27310157-A442D8F3-E7F8-488E-AB3E-7560679ACF57Q30528600-C4F222A7-8D15-4684-A499-88342F77EAF8Q33894807-F7AD82E8-4B20-4CC9-A8A7-C28B0FA4AB89Q34063259-A296C2F2-A2AA-4F4E-A2F0-E604A5604A3CQ34389211-0377B635-8C4F-426D-A91A-9727563DBABBQ34983743-4AE2EF00-53D7-460A-85CE-708DC37D59E0Q35534909-37649475-CDB1-40F6-B854-4AC4EE133781Q35952932-4CEAC4E5-45DB-4F37-9D43-6E03954BD176Q36342150-EA706139-B68E-4919-A976-F9930E6B1FBEQ36511011-94EED717-C4FF-4BB8-A07D-35EEE6194950Q36681974-937897F9-9A0F-435D-AD56-B9EE77CF5D07Q36918739-FC39CDCD-E30B-4038-AF7D-DF535D2EA4B4Q37241166-BBE02831-CF15-48CA-9E25-C2AB8BE2D17AQ37315915-B26828A7-A65D-414D-96E3-415E2771AA34Q37682779-F4B40BA4-3924-4E66-896E-D2726F1B1F2DQ37840780-125A3D33-AC23-4C32-BA36-77B8ED0848EEQ38045578-341991E9-AEB6-44B5-A3EE-82DAAE8E14E6Q38342269-207CB0DC-E1C0-4F1B-B207-7FAA66AB346FQ38642183-200F4109-7815-49BB-8C9A-46C44FA656ADQ38662968-77722308-5B67-47D2-A3EE-99B0BF3DB995Q38790941-F9E4D1CE-6505-4F80-AEA5-78DD182366AAQ38835689-E203D31D-5639-4AD7-B64D-104AAB14E5FAQ39050949-95265407-DF6A-42EE-98D2-7FFE0F8A558BQ39364308-7E9A149C-8DE7-45D7-B966-725D10A8F1ABQ41342320-B7BD4E1F-68AF-4062-AD52-D4D4EF9E4DD0Q41417736-D8AD7C10-4300-4328-BC19-55FCF636CD0CQ41508055-6EA93A09-D85B-4D7B-B08E-485D950C72EFQ42070270-6AB64CCA-DAE5-4E5F-8DB3-49813DCEA2ECQ44703069-2933CF17-4812-4E1B-A3F6-08886A61EA29Q47109443-2C504E0B-DAF7-4487-ABBF-B4F16115E873Q48018704-46E88152-D2EF-41BF-A1CC-6D798D464203Q50487209-6DCB79B5-3AC8-48A3-88E0-4D3A450FDD5CQ53285291-89601DA2-FB47-42CE-9834-D1CD5666702DQ53337219-35408537-1970-43DF-9FB9-0CFA0C498CA3Q54957724-7600094D-8AFE-4E67-ACA7-ECD8C553C0A8Q55315730-7B0F8EE7-7B44-4617-9515-5AC9D8C2A898Q59125620-4ED90964-4E2F-4F8E-8F1B-40EDA9FEEF7E
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Electrophysiological remodeling in heart failure
@ast
Electrophysiological remodeling in heart failure
@en
type
label
Electrophysiological remodeling in heart failure
@ast
Electrophysiological remodeling in heart failure
@en
prefLabel
Electrophysiological remodeling in heart failure
@ast
Electrophysiological remodeling in heart failure
@en
P2860
P1476
Electrophysiological remodeling in heart failure
@en
P2093
Joseph A Hill
Yanggan Wang
P2860
P304
P356
10.1016/J.YJMCC.2010.01.009
P577
2010-01-20T00:00:00Z